STEGLATROTM (ertugliflozin) is a prescription pill that, along with diet and exercise, helps lower blood sugar levels in adults with type 2 diabetes. STEGLATRO is not for people with type 1 diabetes and/or diabetic ketoacidosis (increased ketones in your blood or urine).

STEGLATRO is for adults with type 2 diabetes, in addition to diet and exercise. Not for treating type 1 diabetes or diabetic ketoacidosis.


Get Support
Support Program for STEGLATRO™ (ertugliflozin) Support Program for STEGLATRO™ (ertugliflozin)

Get Support


Sign up for Hello STEGLATRO and get more information.

Sign up for Hello STEGLATRO and get more information.

You work hard every day to manage your type 2 diabetes. You watch what you eat. You exercise more. You take medication as prescribed by your doctor. Wouldn’t it be great to get more information along the way? You’ll receive helpful e-mails on a range of topics, including:

  • Taking STEGLATRO
  • How STEGLATRO works
  • Special offers and more

Let's get started

Please read all the information before completing the form below to enroll.

Merck’s Privacy Commitment

The information you provide will be available to the Merck & Co., Inc., family of companies (collectively, “Merck”) and others working on behalf of Merck, to provide the information and services you request. Personal information about you will not otherwise be disclosed for marketing purposes without your permission. Merck reviews personal information and nonidentifiable information, not only to provide the requested information and services, but also to develop and offer additional services and communications that we believe our customers might find of interest. Merck also may use personal information to audit its resources for compliance and security purposes. For more information about how Merck protects personal information about you, please read our Internet Privacy Policy and Privacy Commitment for US patients, consumers, and caregivers.

You must be 18 years of age or older.

First Name*
Required Field
Last Name*
Required Field
Zip Code
Required Field

By providing your name and other personal information above and clicking the SUBMIT button below, you agree to permit Merck and others working on behalf of Merck to use this information to provide you with information, resources, services, and communications about STEGLATRO, and disease-related materials via e-mail or otherwise. Additionally, your information may be used for market research purposes.

At any time, you can request a copy of this permission and that personal information about you be removed from the Merck contact list for STEGLATRO by calling 888-776-8364. Unless you change this selection sooner, your permission will expire 1 year after Merck no longer promotes STEGLATRO.

By clicking "SUBMIT," I am signing this form. I agree that my information may be used as described above, as well as for market research purposes.

*Required Fields
See Savings Offer


You’re now signed up to receive updates and other resources about STEGLATRO™ (ertugliflozin).



TRUSTe Verified Privacy TRUSTe APEC Privacy

Copyright © 2019 Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. All rights reserved.

This site is intended only for residents of the United States, its territories, and Puerto Rico. US-STE-00656 07/19

Do not take STEGLATRO if you:

  • have severe kidney problems or are on dialysis
  • are allergic to ertugliflozin or any of the ingredients in STEGLATRO. Symptoms of a serious allergic reaction to STEGLATRO may include skin rash, raised red patches on your skin (hives), and swelling of the face, lips, tongue, and throat that may cause difficulty in breathing or swallowing. If you have any symptoms of a serious allergic reaction, stop taking STEGLATRO and call your doctor right away.